NCT06443255View on ClinicalTrials.gov

Cocaine, Lidocaine/xylometazoline and Saline for Nasal Analgesia

PHASE3CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

August 27, 2024

Study Completion Date

August 27, 2024

Conditions
Analgesia
Interventions
DRUG

Cociane hydrochloride 4%

2 mL of 4% cocaine

DRUG

Lidocaine 4%

1.5 mL of 4% lidocaine

DRUG

Xylometazoline 0.1%

0.5 mL of xylometazoline 0.1%

DRUG

Saline 0.9%

2 mL of saline 0.9%

Trial Locations (1)

Unknown

Rigshospitalet, Copenhagen

All Listed Sponsors
lead

Rigshospitalet, Denmark

OTHER